The company is looking to add 400 new centres across the country in next five years taking the total numbers of centres to 500.
"We have closed Rs 100-crore series C funding two days back. This will be used to set up new centres across the country, mainly in tier II, III and tier IV cities," NephroPlus Founder & CEO Vikram Vuppala told PTI.
The company has 75 centres that are operational while 25 are under development, he said, adding, "we plan to open 400 new centres by end of 2021".
"Securing the backing of leading investor like SCP is a strong milestone for us and a strong validation of the impact that we are creating in the dialysis space in India," Vuppala said.
Also Read
The company is also pleased to have continued support from existing investors, he added.
"Our focus will be mainly on non-metros, state capitals and large towns for expansion. The aim is to add 100 more cities in next 5 years from 50 cities that we are in at present," Vuppala said.
"SCP's approach is to go beyond financial investment and to actively partner with high quality companies," SCP Managing Partner Heramb Hajarnavis said. He is also joining the board of NephroPlus.
IFC Venture Capital team head for South Asia Pravan Malhotra said: "IFC had invested in NephroPlus in 2014 to expand the availability of high quality kidney care services in India."
IFC's repeat investment will further expand the provision of quality dialysis care in a market that is still under-served, he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content